Are we Choosing Wisely in lymphoma? Excessive use of surveillance CT imaging in patients with diffuse large B-cell lymphoma (DLBCL) in long-term remission

The use of surveillance computed tomography (CT) imaging in patients with diffuse large B-cell lymphoma (DLBCL) in remission is neither effective nor cost-effective. The American Society of Hematology (ASH) Choosing Wisely (CW) campaign, in particular, emphasizes the lack of benefit beyond 2-years of completion of therapy. We sought to describe the real-world practice of surveillance imaging.

Source: Clinical Lymphoma, Myeloma and Leukemia - October 9, 2017 Category: Hematology Authors: Matthew C. Cheung, Nicole Mittmann, Craig C. Earle, Farah Rahman, Ning Liu, Simron Singh Tags: Original Study Source Type: research